PDT Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,779
| Closed | -$183K | – | 615 |
|
|
2023
Q1 | $183K | Buy |
11,779
+90
| +0.8% | +$1.4K | 0.02% | 507 |
|
|
2022
Q4 | $207K | Sell |
11,689
-506
| -4% | -$8.98K | 0.03% | 532 |
|
|
2022
Q3 | $68K | Sell |
12,195
-123,033
| -91% | -$686K | 0.01% | 800 |
|
|
2022
Q2 | $527K | Hold |
135,228
| – | – | 0.05% | 587 |
|
|
2022
Q1 | $745K | Buy |
135,228
+26,090
| +24% | +$144K | 0.06% | 469 |
|
|
2021
Q4 | $930K | Buy |
+109,138
| New | +$930K | 0.07% | 379 |
|
|
2021
Q3 | – | Sell |
-135,700
| Closed | -$1.43M | – | 831 |
|
|
2021
Q2 | $1.43M | Buy |
+135,700
| New | +$1.43M | 0.09% | 312 |
|